Eyconis is a newly formed company that will develop, manufacture and commercialize TransCon ophthalmology assets.
Eyconis has raised $25.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2025.
Eyconis is headquartered in Redwood City, United States.
Eyconis is a newly formed company that will develop, manufacture and commercialize TransCon ophthalmology assets.
Eyconis is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eyconis — Funding & Investors." VCBacked, October 22, 2025, https://www.vcbacked.co/company/eyconis. Accessed August 15, 2026.
VCBacked. (2025). Eyconis — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/eyconis
{{cite web |title=Eyconis — Funding & Investors |url=https://www.vcbacked.co/company/eyconis |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated